Selecxine
Songpadong
About Selecxine
Selecxine is a biopharmaceutical development company specialized in the field of immunotherapeutics. Selecxine strives to develop immunotherapeutics a new paradigm of pharmaceuticals– through a specialized antibody development process, using an innovative platform technology of functional antibody screening and development.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $27.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: selecxine.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/selecxine-39408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.